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Symphysis-fundal height curve 
in the diagnosis of fetal growth 
deviations
Curva de altura uterina por idade 
gestacional e diagnóstico de desvios 
do crescimento fetal
ABSTRACT
OBJECTIVE: To validate a new symphysis-fundal curve for screening fetal 
growth deviations and to compare its performance with the standard curve 
adopted by the Brazilian Ministry of Health.
METHODS: Observational study including a total of 753 low-risk pregnant 
women with gestational age above 27 weeks between March to October 
2006 in the city of João Pessoa, Northeastern Brazil. Symphisys-fundal 
was measured using a standard technique recommended by the Brazilian 
Ministry of Health. Estimated fetal weight assessed through ultrasound using 
the Brazilian fetal weight chart for gestational age was the gold standard. A 
subsample of 122 women with neonatal weight measurements was taken up to 
seven days after estimated fetal weight measurements and symphisys-fundal 
classifi cation was compared with Lubchenco growth reference curve as gold 
standard. Sensitivity, specifi city, positive and negative predictive values were 
calculated. The McNemar χ2 test was used for comparing sensitivity of both 
symphisys-fundal curves studied.
RESULTS: The sensitivity of the new curve for detecting small for gestational 
age fetuses was 51.6% while that of the Brazilian Ministry of Health reference 
curve was signifi cantly lower (12.5%). In the subsample using neonatal weight 
as gold standard, the sensitivity of the new reference curve was 85.7% while 
that of the Brazilian Ministry of Health was 42.9% for detecting small for 
gestational age.
CONCLUSIONS: The diagnostic performance of the new curve for detecting 
small for gestational age fetuses was signifi cantly higher than that of the 
Brazilian Ministry of Health reference curve.
DESCRIPTORS: Embryonic and Fetal Development. Uterus, growth 
& development. Gestational Age. Ultrasonography, Prenatal. Prenatal 
Diagnosis. Validation Studie.
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Serial measurement of symphysis-fundal height (SFH) 
during pregnancy is a major clinical tool to evaluate 
fetal growth as well as to identify other pregnancy 
complications.a It is an easy-to-use low-cost tool, 
although it has not been widely confi rmed as a reliable 
measurement in the prenatal care routine. Belizan et al4 
showed these serial measurements greatly improve the 
predictive capacity of detecting fetal growth abnormali-
ties. The Brazilian Ministry of Health (BMoH) recom-
mends the use of a standard SFH curve developed by 
Fescina et al.9 Normal uterine growth is within the 10th 
and the 90th percentiles.b However, studies have reported 
different SFH patterns for Brazilian populations,10,18,21 
and these differences could be explained not only by 
specifi c characteristics of ethnic groups but also by 
other factors such as different measurement techniques, 
risk level, socioeconomic and nutritional conditions, 
gestational age estimates and number of examiners.
RESUMO
OBJETIVO: Validar curva de referência de altura uterina por idade gestacional 
para o rastreamento de desvios do crescimento fetal e comparar sua performance 
com a curva-padrão adotada pelo Ministério da Saúde do Brasil.
MÉTODOS: Estudo observacional que envolveu 753 gestantes de baixo risco 
de João Pessoa, PB, entre março e outubro de 2006, com idade gestacional 
acima de 27 semanas. A altura uterina foi medida de acordo com técnica 
preconizada pelo Ministério da Saúde. O padrão-ouro foi o peso fetal, 
estimado pelo ultrassom com base na curva de referência brasileira por idade 
gestacional. Uma subamostra de 122 casos com pesos neonatais obtidos até 
sete dias depois da estimativa do peso fetal, a classifi cação da altura uterina 
foi comparada com a curva de Lubchenco como padrão-ouro. A sensibilidade, 
a especifi cidade e os valores preditivos positivo e negativo foram calculados. 
Para comparar o desempenho da sensibilidade entre ambas as curvas de altura 
uterina, utilizou-se o teste χ2 de McNemar.
RESULTADOS: A sensibilidade da nova curva para a detecção de fetos 
pequenos para a idade gestacional foi de 51,6%, enquanto a da curva do padrão-
ouro foi signifi cativamente menor (12,5%). Na subamostra que teve o peso 
neonatal como padrão-ouro, a sensibilidade da nova curva de referência foi 
de 85,7%, enquanto a do Ministério da Saúde exibiu 42,9% de sensibilidade 
para a detecção de fetos pequenos para a idade gestacional.
CONCLUSÕES: A capacidade diagnóstica da nova curva de referência para 
detectar fetos pequenos para a idade gestacional foi signifi cativamente melhor 
do que a da curva recomendada pelo Ministério da Saúde.
DESCRITORES: Desenvolvimento Embrionário e Fetal. Útero, 
crescimento & desenvolvimento. Idade Gestacional. Ultrassonografi a 
Pré-Natal. Diagnóstico Pré-Natal. Estudos de Validação.
INTRODUCTION
a Ministério da Saúde. Pré-natal e puerpério: atenção qualifi cada e humanizada: manual Técnico. 2.ed. Brasília, DF; 2006.
b National Collaborating Center for Women’s and Children’s Health. Antenatal care: routine care for the healthy pregnant woman. 
Clinical Guideline. 2.ed. London: RCOG Press; 2009 [cited 2009 Sep 9]. Available from: http://www.nice.org.uk/nicemedia/pdf/
CG62FullGuidelineCorrected June2008July2009.pdf
The relationship between SFH and gestational age can 
provide clinical indications of fetal growth deviations. 
However, studies have found inconsistent perfor-
mance results.4,9,11,19,21 Despite the lack of a single 
reliable method to identify fetal growth deviations, 
combined clinical and ultrasound methods improve 
diagnosis.5,6,15,18 As for the diagnosis of fetal growth 
restriction, newborn’s weight is only a fi nal measure-
ment which does not allow any kind of intervention 
to manage fetal weight gain.5,6 On the other hand, 
fetal weight estimates using ultrasound provides 
data that enable to diagnose conditions that may be 
impairing fetal growth.5,6 However, the SFH curve is 
a non-invasive, easy-to-use, low-cost tool that may be 
used to support important clinical decisions for either 
diagnostic or therapeutic interventions in developing 
countries where access to sophisticated technological 
resources for the assessment of fetal growth is not 
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always available. Although SFH curves are usually used 
to screen fetal growth restriction, there are concerns 
about their performance.
Freire et al10 have demonstrated that the UH growth 
curve developed with low risk pregnant women from 
Joao Pessoa (Northeastern Brazil), differs signifi cantly 
from that adopted by the BMoH9 as the standard for the 
Brazilian population.
Differences between both curves, the one from Freire 
et al10 and that from Fescina et al9 used by the BMoH, 
raise the hypothesis that they perform differently when 
identifying normal fetal growth and any deviations. 
Therefore, since one of the main applications of SFH 
measurements in prenatal care is for screening fetal 
growth deviations,a the standard curve may not be effec-
tive enough for this purpose, over or under diagnosing 
those conditions because it is based in a sample of 
women with a pattern of fetal growth different from 
that of the Brazilian population. The objective of the 
present study was to validate the SFH growth curve as a 
standard method for the screening of fetal growth devia-
tions and to compare its performance with the pattern 
curve adopted by the Brazilian Ministry of Health.
METHODS
The validation of a SFH reference curve for gestational 
age was based on a curve developed by Freire et al.10 The 
present study was carried out in a university hospital and 
a public maternity hospital in the city of João Pessoa, 
Northeastern Brazil, from March to October 2006. These 
hospitals were selected as they are reference centers of 
prenatal care in the public health service and they have 
higher demand of pregnant women. Eligibility of preg-
nant women was assessed in the ultrasound department 
of these hospitals. The sample size was calculated based 
on an estimated prevalence of 12% intra-uterine growth 
restriction in this population.a An 80% sensitivity for 
SFH measurements was assumed for detection of actual 
fetal growth restriction in the sample, with a sampling 
error of 9.2% and type I error of 0.05. The estimated 
sample size was 750 pregnant women. A sample of 753 
pregnant women was selected according to free demand 
for each prenatal service.
The inclusion criteria included gestational age above 26 
weeks, with a known last menstrual period or confi rmed 
by ultrasound during the fi rst half of pregnancy. Women 
who were pregnant with twins, fetal death or any fetal 
malformations that prevented the assessment of fetal 
weight and the amniotic fl uid index by ultrasound were 
excluded. The following variables were studied: SFH, 
gestational age, ultrasound-derived estimated fetal 
weight (EFW), and fetal growth deviation (categorized 
by gestational age in small – lower than the 10th percen-
tile; large – higher than the 90th percentile; and adequate 
– between the 10th and the 90th percentiles). Data was 
also collected for the following control variables: age; 
body mass index (BMI, classifi ed by reference values 
for each gestational age according to Atalah et al1 as 
recommended by the BMoH); ethnic group/skin color; 
number of pregnancies; parity; previous caesarean 
sections; previous abortions and smoking habits.
SFH was measured with a fl exible inelastic measuring 
tape from the pubic symphysis to the uterine fundus 
after correction of uterine dextrorotation, following 
the standard technique as recommended by the 
BMoH.10,a Fetal weight was estimated by ultrasound 
using Hadlock et al formula13 as described elsewhere.5 
The gold standard for classifying EFW was adapted 
from the curve developed by Cecatti et al5 with normal 
EFW percentiles established by ultrasound according 
to gestational age in a Brazilian population using third 
degree polynomial adjustments. We opted for this 
method due to high linear correlation previously found 
between EFW and neonatal weight.6
SFH measurements were taken in pregnant women 
attending prenatal care visits for routine ultrasound 
examination. Data was recorded in standard forms by the 
examiner. Ultrasound scans were performed with GE® 
Voluson 730 PRO and GE® Logic 500 equipment, both 
with multifrequency (2.5–5.0 MHz) convex probes.
For statistical analysis, SFH and EFW values for each 
pregnant woman in the study were plotted on their 
related charts as a function of gestational age and were 
compared to related standards. To validate Freire et al 
SFH growth curve,10 sensitivity, specifi city, positive and 
negative predictive values were calculated for screening 
fetal growth deviation. The gold standard for diag-
nosing SGA and large for gestational age (LGA) fetuses 
was the classifi cation of fetal weight using ultrasound-
derived EFW reference curve developed by Cecatti et 
al.5 The same procedure was then performed with the 
BMoH SFH curve. For the comparison of sensitivity, 
the McNemar’s χ2 test was used for non-independent 
samples with Yates’ correction.
In a subsample of 122 women SFH measurements were 
taken up to seven days before delivery. Additionally, 
SFH classifi cation was compared with neonatal weight 
classifi cation based on Lubchenco et al’s curve17 as the 
gold standard. SFH sensitivity for the diagnosis of fetal 
growth deviations was also compared with that of the 
BMoH standard SFH curve. A level of signifi cance of 
5% was set. For statistic analysis EpiInfo 2000 and 
Excel™ software were used.
The study protocol was approved by the Institutional 
Review Board of the Centro de Ciências da Saúde da 
Universidade Federal da Paraíba (3/23/2005) and the 
Instituto e Maternidade Cândida Vargas (3/11/2005).
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RESULTS
The age of the 753 women studied ranged between 13 
and 45 years old, with mean age of 26.5. The predomi-
nant ethnic group/skin color was white (46.6%); BMI 
ranged between 18.9 kg/m2 and 37.8 kg/m2 with mean 
BMI of 27 kg/m2. Most of them did not smoke (97.6%). 
Table 1 shows that 47.5% were primigravida, 50% had 
never had a delivery and 17.2% had previous cesarean 
sections. Gestational age ranged between 29 and 41 
weeks, and most were over 32 weeks of pregnancy.
Figure 1 shows the distribution of SFH measurements 
against the 10th percentile and the 90th percentile in 
Freire et al SFH curve.10 The majority of cases were 
considered adequate (64.3%) and 10.5% were SGA. 
Compared to Cecatti et al curve,5 the proportion of 
adequate growth increased (70.1%) while the propor-
tion of SGA (8.5%) and LGA (21.4%) decreased.
The sensitivity of SFH curve for the diagnosis of SGA 
and LGA, using the ultrasound-derived EFW curve as 
gold standard, is outlined in Table 2. Table 3 shows the 
sensitivity of SFH curve for the diagnosis of SGA and 
LGA using the neonatal weight curve as gold standard. 
The sensitivity of Freire et al11 curve for detecting SGA 
was 51.6% while that of the BMoH curve was only 
12.5%, a statistically signifi cant difference. When using 
actual neonatal weight, the sensitivity of the SFH curve 
was also higher for detecting SGA (85.7%) than that of 
the BMoH curve (42.9%).
DISCUSSION
This study validated the SFH curve developed by 
Freire et al10 and compared its performance with that 
of the BMoH curvea in a population of pregnant women 
under conditions similar to those seen in public health 
facilities in Brazil. This sample characteristic may 
be attributed to BMI distribution in the population 
as a signifi cant association between BMI and SFH 
measurement was seen (data not shown). Almost half 
of pregnant women with fetal growth lying above the 
90th percentile was classifi ed as overweight or obese,a 
higher proportion than those below the 90th percentile 
in the SFH curve (23.1%) (p<0.0001; data not shown). 
The BMI in the sample seems to refl ect the behavior 
of ultrasound-derived EFW, which showed 8.5% of 
SGA and 21.4% of LGA. BMI was also signifi cantly 
associated with EFW (p<0.001; data not shown) as the 
proportion of overweight or obese pregnant women was 
signifi cantly higher in the LGA (41.0%) than in the 
non-LGA group (25.7%). This may explain the high 
prevalence of LGA in the sample, as well as refl ect the 
so-called “obesity epidemics” as currently described 
in Western societies.
In general, studies on fetal growth curves among 
Brazilian women19 use Hadlock et al curve13 as a 
reference. However, a fetal growth curve created 
from a specifi c Brazilian population would be more 
appropriate, so the present study used the EFW curve, 
which was developed based on a sample of Brazilian 
women5,6 to assess SFH for diagnosing SGA and LGA. 
There is a wide variation in the performance of SFH 
measurements as a method for screening fetal growth 
Table 1. Percentage distribution of pregnant women according 
to demographic and obstetric characteristics. João Pessoa, 
Northeastern Brazil, 2006.
Variable n %
Age (years)
14–19 105 13.9
20–24 188 25.0
25–29 217 28.8
≥30 243 32.3
Ethnic group/skin color
White 351 46.6
Mixed 341 45.3
Black 61 8.1
Body mass index 
Low weight 142 18.9
Adequate 390 51.8
Overweight 162 21.5
Obesity 59 7.8
Smoking
Yes 18 2.4
No 735 97.6
Number of pregnancies
1 360 47.8
2 229 30.4
3 109 14.5
≥4 55 7.3
Parity
0 380 50.5
1 252 33.5
2 96 12.7
≥3 25 3.3
Previous caesarean sections
Yes 145 19.3
No 608 80.7
Previous abortions
Yes 86 11.4
No 667 88.6
Gestational age
27–31 150 19.9
32–36 282 37.5
≥37 321 42.6
Total 753 100.0
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deviation, especially when detecting SGA fetuses. It 
seems that the variation in the diagnostic performance 
between SFH reference curves is infl uenced not only by 
sociodemographic characteristics, but also by different 
methods used in the studies, the standardization of the 
technique used to measure SFH, the population under 
study (high- and low-risk pregnant women), and criteria 
used to defi ne fetal growth restriction.
Belizan et al4 fi rst reported 86% sensitivity and 90% 
specifi city with 10% false positives, and concluded 
that SFH measurements can be used in the prenatal 
care to screen for fetal growth restrictions. Ghate et al12 
assessed the performance of the SFH curve in predicting 
low-weight newborns and they found 87.5% sensitivity, 
90% specifi city and a positive predictive value of 
77.8%. In the present study, the sensitivity of 51.6% 
of SFH in detecting SGA using EFW as gold standard 
is adequate to recommend its use for screening fetal 
growth deviation during prenatal care. The sensitivity 
of 85.7% of the SFH in detecting SGA in newborns of 
Table 2. Performance of the symphysis-fundal height curve for the diagnosis of small for gestational age and large for gestational 
age (n=753) with the ultrasound-derived estimated fetal weight curve as gold standard and comparison with the symphysis-
fundal height curve of the Brazilian Ministry of Health. João Pessoa, Northeastern Brazil, 2006.
Symphysis-fundal height Ultrasound-derived estimated fetal weight
SGA No-SGA
SGA 33 46
No-SGA 31 643
Total 64 689
LGA No-LGA
LGA 91 99
No-LGA 70 493
Total 161 592
Performance
SGA LGA
SFH curve(%) BMoH curve (%) SFH curve (%) BMoH curve (%)
Sensitivity 51.6 * 12.5 * 56.5 84.5
Specifi city 93.3 98.4 84.3 52.9
Positive predictive value 41.8 42.1 47.9 32.8
Negative predictive value 95.4 92.4 87.6 92.6
(*) signifi cant difference; McNemar’s χ² with Yates’ correction = 23.04; p<0.0001
SGA: small gestational age; LGA: large gestational age; SFH: symphysis-fundal height; BMoH: Brazilian Ministry of Health
Table 3. Performance of the symphysis-fundal height curve for the diagnosis of small for gestational age and large for gestational 
age (n=122) with the neonatal weight curve as the gold standard and comparison with the symphysis-fundal height curve of 
the Brazilian Ministry of Health. João Pessoa, Northeastern Brazil, 2006.
Symphysis-fundal height Neonatal Weight
SGA No-SGA
SGA 12 7
No-SGA 2 101
Total 14 108
LGA No-LGA
LGA 8 20
No-LGA 10 84
Total 18 104
Performance
SGA LGA
SFH curve (%) BMoH curve (%) SFH curve (%) BMoH curve (%)
Sensitivity 85.7 42.9 44.4 88.9
Specifi city 93.5 99.1 80.8 51.0
Positive predictive value 63.2 85.7 28.6 23.9
Negative predictive value 98.1 93.0 89.4 96.4
SGA: small gestational age; LGA: large gestational age; SFH: symphysis-fundal height; BMoH: Brazilian Ministry of Health
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this study supports this recommendation as it shows a 
higher performance than that of the BMoH standard 
curve. Villar & Belizan23 and Engstrom & Sittler8 
studies also indicated that SFH is an important and 
helpful measurement in the clinical diagnosis, not only 
in the screening of fetal growth deviation, but also to 
identify complications during pregnancy and errors in 
estimating gestational age. The charts may help identify 
low weight fetuses and allow appropriate interventions 
during prenatal care.
Fescina et al9 reported 50% sensitivity and 93% speci-
fi city and concluded that SFH measurement is an excel-
lent method to identify fetuses with adequate weight for 
gestational age. This curve was accepted as a reference 
standard for Latin America and the Caribbean in 1984, 
and later by the BMoH.a Since high sensitivity is a key 
characteristic of a good screening method, the use of 
this curve currently recommended by the BMoH in 
Brazil may be, at least, questionable. Even though a 
sensitivity of 51.6% is lower than that desired for an 
excellent screening method, Freire et al’s curve10 has 
performed better than the BMoH curve in the clinical 
practice context. Other Brazilian studies also showed 
better performance of other curves19,21 in comparison to 
that of the BMoH curve, supporting the recommenda-
tion to validate curves directly derived from Brazilian 
populations. Maybe these curves would be more appro-
priate in Brazil, improving the probability of screening 
fetal growth deviations when used as a diagnostic 
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Figure 1. Distribution of 753 symphysis-fundal height measurements for the 10th percentile and the 90th percentile of Freire’s 
curve. João Pessoa, northeastern Brazil, 2006.
Figure 2. Distribution of 753 estimated fetal weight measurements for the 10th percentile and the 90th percentile of Cecatti et 
al. curve. João Pessoa, Northeastern Brazil, 2006.
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resource in prenatal care. Ideally, all measurements of 
these different studies could be pooled in a common 
Brazilian reference SFH curve.
According to Freire et al,10 the SFH growth curve of 
pregnant women from public hospitals in the city of 
João Pessoa signifi cantly differs from the standard 
curve recommended by the BMoH.9 Some other studies 
have investigated curves developed from a Brazilian 
population of pregnant women, however these curves 
differ methodologically from the present curve, espe-
cially in the SFH measurement technique and variation 
between examiners.18
Although Neilson20 claimed there is a lack of evidence 
indicating any real benefi t of using SFH measurement 
in prenatal care, many countries have prenatal care 
protocols recommending its use along with refer-
ence curves designed for the population of interest.b 
Despite technological improvements, the real benefi t 
of obstetric ultrasound, when used in the clinical 
routine as a screening method for fetal growth restric-
tion in low-risk populations, is not yet supported by 
strong scientifi c evidence.2,14 Considering that even in 
developed countries it is estimated that approximately 
50% of SGA fetuses are only identifi ed at birth or 
death, and that this number is likely to be higher in 
developing countries, it is reasonable to accept the 
use of a low-cost method like the SFH measurement, 
even without excellent sensitivity. In a recent study 
Lindqvist & Molin16 showed that SGA fetuses that 
were not diagnosed during prenatal care have a four 
times greater risk of developing unfavorable outcomes 
than those diagnosed during prenatal care. This data 
emphasizes the need for assessing feasible screening 
methods that are appropriate to the reality of mother-
infant health care.
One of the limitations of the present study is that we 
could not correlate neonatal outcome in the entire 
sample as only 122 cases (16.2%) had neonatal weight 
determined up to seven days after SFH and EFW 
measurements. However, a high linear correlation 
between EFW and neonatal weight (r = 0.94) was 
found in this subsample, which was considered to be 
more than enough to ascertain a strong association.11 
Therefore, this fi nding supported the classifi cation of 
EFW as the gold standard to diagnose fetal growth 
deviation in this study. Another limitation is regarding 
its cross-sectional design. As each pregnant woman 
had her SFH measurement assessed only once, it was 
not possible to evaluate the individual standard of 
SFH growth. Hypothetically, some undetected cases 
of SGA (false negatives) could have a reduction of 
SFH between two consecutive measurements. This 
hypothesis is consistent with new conceptual aspects 
of fetal growth restriction, which consider detecting a 
reduction in fetal weight a more important diagnostic 
criterion than the use of predetermined percentiles in 
fetal weight curves.3,7,22
Based on these results, important questions are posed 
in the area of public health. For instance, what would 
be the economic and perinatal impact of using a new 
and better SFH curve in the Brazilian population? A 
nationwide cohort study on maternal weight gain and 
fetal growth patterns would be the desirable for better 
understanding this relationship.
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